AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 117 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,531 | -18.1% | 33,317 | +2.4% | 0.00% | 0.0% |
| Q2 2023 | $1,869 | +40.6% | 32,537 | -8.3% | 0.00% | +33.3% |
| Q1 2023 | $1,329 | +25.1% | 35,490 | -6.5% | 0.00% | 0.0% |
| Q4 2022 | $1,062 | -99.9% | 37,965 | -10.4% | 0.00% | 0.0% |
| Q3 2022 | $1,189,000 | -8.8% | 42,367 | +12.9% | 0.00% | 0.0% |
| Q2 2022 | $1,304,000 | +9.7% | 37,512 | +16.2% | 0.00% | +50.0% |
| Q1 2022 | $1,189,000 | +57.3% | 32,276 | -0.7% | 0.00% | 0.0% |
| Q4 2021 | $756,000 | +20.6% | 32,491 | -0.6% | 0.00% | +100.0% |
| Q3 2021 | $627,000 | +2.1% | 32,694 | +7.4% | 0.00% | 0.0% |
| Q2 2021 | $614,000 | +10.2% | 30,450 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $557,000 | -21.5% | 30,450 | -13.7% | 0.00% | 0.0% |
| Q4 2020 | $710,000 | -6.6% | 35,293 | -12.9% | 0.00% | -50.0% |
| Q3 2020 | $760,000 | -18.0% | 40,509 | -2.0% | 0.00% | 0.0% |
| Q2 2020 | $927,000 | +44.4% | 41,333 | -5.2% | 0.00% | 0.0% |
| Q1 2020 | $642,000 | -22.1% | 43,590 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $824,000 | -15.8% | 43,085 | -7.3% | 0.00% | 0.0% |
| Q2 2019 | $979,000 | +3.2% | 46,463 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $949,000 | +18.0% | 46,463 | +5.9% | 0.00% | +50.0% |
| Q4 2018 | $804,000 | -4.7% | 43,863 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $844,000 | +26.2% | 43,863 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $669,000 | -18.6% | 43,863 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $822,000 | -7.7% | 43,863 | -5.3% | 0.00% | 0.0% |
| Q4 2017 | $891,000 | +7.6% | 46,337 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $828,000 | -8.8% | 46,337 | -8.9% | 0.00% | 0.0% |
| Q2 2017 | $908,000 | +23.0% | 50,874 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $738,000 | -11.0% | 50,874 | +13.0% | 0.00% | 0.0% |
| Q4 2016 | $829,000 | -55.4% | 45,033 | -54.1% | 0.00% | -33.3% |
| Q3 2016 | $1,860,000 | +1622.2% | 98,066 | +1363.7% | 0.00% | – |
| Q2 2016 | $108,000 | +35.0% | 6,700 | 0.0% | 0.00% | – |
| Q1 2016 | $80,000 | -15.8% | 6,700 | 0.0% | 0.00% | – |
| Q4 2015 | $95,000 | +21.8% | 6,700 | 0.0% | 0.00% | – |
| Q3 2015 | $78,000 | -33.3% | 6,700 | 0.0% | 0.00% | – |
| Q2 2015 | $117,000 | – | 6,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |